BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34680242)

  • 1. The Prevalence of Pathogenic or Likely Pathogenic Germline Variants in a Nationwide Cohort of Young Colorectal Cancer Patients Using a Panel of 18 Genes Associated with Colorectal Cancer.
    Frostberg E; Petersen AH; Bojesen A; Rahr HB; Lindebjerg J; Rønlund K
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome.
    Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI;
    Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
    Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline Genetic Features of Young Individuals With Colorectal Cancer.
    Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
    Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016-2021.
    Roht L; Tooming M; Rekker K; Roomere H; Toome K; Murumets Ü; Šamarina U; Õunap K; Kahre T
    Front Genet; 2022; 13():1020543. PubMed ID: 36425062
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6.
    Morak M; Käsbauer S; Kerscher M; Laner A; Nissen AM; Benet-Pagès A; Schackert HK; Keller G; Massdorf T; Holinski-Feder E
    Fam Cancer; 2017 Oct; 16(4):491-500. PubMed ID: 28528517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characteristics of young-onset colorectal cancer in Vietnamese patients.
    Do MD; Nguyen TH; Le KT; Le LHG; Nguyen BH; Le KT; Doan TPT; Ho CQ; Nguyen HN; Tran TD; Vu HA
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):678-685. PubMed ID: 35098669
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Poaty H; Bouya LB; Lumaka A; Mongo-Onkouo A; Gassaye D
    Glob Med Genet; 2023 Jan; 10(1):1-5. PubMed ID: 36644715
    [No Abstract]   [Full Text] [Related]  

  • 10. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.
    Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K
    Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline variant testing in serrated polyposis syndrome.
    Murphy A; Solomons J; Risby P; Gabriel J; Bedenham T; Johnson M; Atkinson N; Bailey AA; Bird-Lieberman E; Leedham SJ; East JE; Biswas S
    J Gastroenterol Hepatol; 2022 May; 37(5):861-869. PubMed ID: 35128723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic insights: High germline variant rate in an indigenous African cohort with early-onset colorectal cancer.
    Yildiz S; Musarurwa TN; Algar U; Chambuso R; Rebello G; Goldberg PA; Ramesar R
    Front Oncol; 2023; 13():1253867. PubMed ID: 37965459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
    Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
    Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach.
    Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF
    Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Mao R; Krautscheid P; Graham RP; Ganguly A; Shankar S; Ferber M; Hegde M;
    Genet Med; 2021 Oct; 23(10):1807-1817. PubMed ID: 34140662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for germline mutations in mismatch repair genes in patients with Lynch syndrome by next generation sequencing.
    Soares BL; Brant AC; Gomes R; Pastor T; Schneider NB; Ribeiro-Dos-Santos Â; de Assumpção PP; Achatz MIW; Ashton-Prolla P; Moreira MAM
    Fam Cancer; 2018 Jul; 17(3):387-394. PubMed ID: 28932927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
    Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
    Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
    J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
    Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
    PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
    Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
    Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.